Brooks O'Neil
Stock Analyst at Lake Street
(0.93)
# 3,776
Out of 4,896 analysts
37
Total ratings
30.56%
Success rate
-16.38%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $12 → $18 | $11.26 | +59.86% | 2 | Jul 10, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $6.23 | +221.03% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $30.84 | +39.43% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $83.65 | +31.50% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $12.67 | +136.78% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $45.53 | +55.94% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $3.21 | +211.53% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $5.70 | +145.61% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $12.01 | +116.49% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $34.93 | +57.46% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $10.99 | +63.79% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.30 | +16.28% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $15.59 | +381.08% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.66 | +80.32% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $19.08 | +36.27% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $5.25 | +757.14% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.71 | +1,460.28% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $34.67 | +267.75% | 1 | Sep 15, 2020 |
LifeMD
Jul 10, 2025
Maintains: Buy
Price Target: $12 → $18
Current: $11.26
Upside: +59.86%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $6.23
Upside: +221.03%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $30.84
Upside: +39.43%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $83.65
Upside: +31.50%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $12.67
Upside: +136.78%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $45.53
Upside: +55.94%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.21
Upside: +211.53%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.70
Upside: +145.61%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.01
Upside: +116.49%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $34.93
Upside: +57.46%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $10.99
Upside: +63.79%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.30
Upside: +16.28%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $15.59
Upside: +381.08%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.66
Upside: +80.32%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $19.08
Upside: +36.27%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $5.25
Upside: +757.14%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.71
Upside: +1,460.28%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $34.67
Upside: +267.75%